Survival risk prediction model for patients with pT1-3 N0M0 esophageal squamous cell carcinoma after R0 esophagectomy with two-field lymphadenectomy for therapeutic purposes.
机构:[1]Department of thoracic surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.临床科室胸心外科(胸外科 心脏血管外科)河北医科大学第四医院[2]Department of Radiation Oncology, Fourth Hospital of Hebei Medical University, No.12, Jiankang road, Shijiazhuang, 050011, China.河北医科大学第四医院[3]Hebei Clinical Research Center for Radiation Oncology, Shijiazhuang, China.[4]Department of CT/MRI, Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China医技科室CT磁共振科河北医科大学第四医院
The overall survival (OS) remains unsatisfactory in patients with esophageal squamous cell carcinoma (ESCC) after extended esophagectomy with two-field lymphadenectomy. Therefore, this retrospective study aimed to identify the risk factors that contribute to the low survival of patients with pT1-3N0M0 ESCC.
Patients with pT1-3N0M0 ESCC who only underwent R0 esophagectomy with two-field lymphadenectomy in our department from January 2008 to December 2012 were retrospectively enrolled in this study and medical records were reviewed. Postoperative OS, disease-free survival (DFS), recurrence-free survival (RFS), and locoregional recurrence-free survival (LRFS) were analyzed sequentially.
This study recruited a total of 488 patients, whose follow-up visits were completed at the end of December 2019. The five-year OS, DFS, RFS and LRFS rates were 62.1, 53.1, 58.3 and 65.6%, respectively. Multivariate Cox analysis identified patient age, site of the lesion, small mediastinal lymph nodes in CT imaging (SLNs in CT), dissected lymph nodes (LNs), and stage of esophageal malignancy as independent risk factors for OS of the patients. Of these factors, the site of the lesion, SLNs in CT and stage of the cancer were determined to be independent factors for DFS, RFS and LRFS. Based on all five factors, the recursive partitioning analysis (RPA) score system was developed to stratify the patients into low-, medium- and high-risk groups, which were found to possess significantly different rates of OS, DFS, RFS and LRFS (p < 0.001).
Several factors were associated with the survival of patients with pT1-3 N0M0 ESCC who underwent extended esophagectomy with two-field lymphadenectomy. These factors contributed to the RPA scoring system, which could stratify the risk of postoperative survival and may expedite the initiation of postoperative adjuvant therapy.
第一作者机构:[1]Department of thoracic surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.
通讯作者:
通讯机构:[2]Department of Radiation Oncology, Fourth Hospital of Hebei Medical University, No.12, Jiankang road, Shijiazhuang, 050011, China.[3]Hebei Clinical Research Center for Radiation Oncology, Shijiazhuang, China.
推荐引用方式(GB/T 7714):
Qi Zhan,Hu Yuanping,Qiu Rong,et al.Survival risk prediction model for patients with pT1-3 N0M0 esophageal squamous cell carcinoma after R0 esophagectomy with two-field lymphadenectomy for therapeutic purposes.[J].JOURNAL OF CARDIOTHORACIC SURGERY.2021,16(1):doi:10.1186/s13019-021-01503-0.
APA:
Qi Zhan,Hu Yuanping,Qiu Rong,Li Juan,Li Yuekao...&Wang Yuxiang.(2021).Survival risk prediction model for patients with pT1-3 N0M0 esophageal squamous cell carcinoma after R0 esophagectomy with two-field lymphadenectomy for therapeutic purposes..JOURNAL OF CARDIOTHORACIC SURGERY,16,(1)
MLA:
Qi Zhan,et al."Survival risk prediction model for patients with pT1-3 N0M0 esophageal squamous cell carcinoma after R0 esophagectomy with two-field lymphadenectomy for therapeutic purposes.".JOURNAL OF CARDIOTHORACIC SURGERY 16..1(2021)